Skip to content

Effectiveness and patient satisfaction of a Dutch patient Decision Aid Psoriasis

Effectiveness and patient satisfaction of a Dutch patient Decision Aid Psoriasis (ESDDAP) – A PILOT STUDY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28770
Enrollment
30
Registered
2019-10-25
Start date
2019-09-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis Vulgaris

Interventions

A Dutch PDA psoriasis ('Keuzehulp Psoriasis - Systemische Medicatie') and corresponding implementation training for dermatologists.

Sponsors

Amsterdam UMC - location AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Age of = 18 -Confirmed psoriasis by (resident) dermatologist -Eligible for systemic therapy according to the Dutch national guideline psoriasis

Exclusion criteria

Exclusion criteria: -Insufficient understanding of the Dutch language or cognitively unable to complete Dutch questionnaires. -Absence of willingness to use the PDA Psoriasis

Design outcomes

Primary

MeasureTime frame
Level of SDM measured with OPTION-5 score

Secondary

MeasureTime frame
Level of SDM measured with SDM-Q-9 score, SDM-Q-Doc score and CollaboRATE score; Patient Satisfaction with the consultation measured with VAS score 0-9, and decisional conflict measured with Decisional Conflict Scale.

Contacts

Public ContactAstrid van Huizen

Amsterdam UMC

a.m.vanhuizen@amsterdamumc.nl020-5668109

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)